[en] Positive allosteric modulators of the ionotropic glutamate receptor-2 (GluA2) are promising compounds for the treatment of cognitive disorders, e.g. Alzheimer’s disease. These modulators bind within the dimer interface of the LBD (ligand-binding domain) and stabilize the agonist-bound conformation slowing receptor desensitization and/or deactivation. In the present study, we employ isothermal titration calorimetry to determine binding affinities and thermodynamic details of binding of modulators of GluA2. A mutant of the LBD of GluA2 (LBD-L483Y-N754S) that forms a stable dimer in solution was used. The potent GluA2 modulator BPAM-97 was used as a reference compound. Evidence that BPAM-97 binds in the same pocket as the well-known GluA2 modulator cyclothiazide was obtained from X-ray structures. The LBD-L483Y-N754S:BPAM-97 complex has aKd of 5.6 μM (Δ H = − 4.9 kcal/mol, − T Δ S = − 2.3 kcal/mol; where 1 kcal ≈4.187 kJ). BPAM-97 was used in a displacement assay to determine a Kd of 0.46 mM (Δ H = − 1.2 kcal/mol, − T Δ S = − 3.3 kcal/mol) for the LBD-L483Y-N754S:IDRA-21 complex. The major structural factors increasing the potency of BPAM-97 over IDRA-21 are the increased van der Waals contacts to, primarily, Met496 in GluA2 imposed by the ethyl substituent of BPAM-97. These results add important information on binding affinities and thermodynamic details, and provide a new tool in the development of drugs against cognitive disorders. Key words: binding affinity, crystal structure, ionotropic glutamate receptor, isothermal titration calorimetry, positive allosteric modulator
Bowie, D. (2008) Ionotropic glutamate receptors & CNS disorders. CNS Neurol. Disord. Drug Targets 7, 129-143
Sobolevsky, A. I., Rosconi, M. P. and Gouaux, E. (2009) X-ray structure, symmetry and mechanism of an AMPA-subtype glutamate receptor. Nature 462, 745-756
Armstrong, N. and Gouaux, E. (2000) Mechanisms for activation and antagonism of an AMPA-sensitive glutamate receptor: crystal structures of the GluR2 ligand binding core. Neuron 28, 165-181
Armstrong, N., Jasti, J., Beich-Frandsen, M. and Gouaux, E. (2006) Measurement of conformational changes accompanying desensitization in an ionotropic glutamate receptor. Cell 127, 85-97 (Pubitemid 44466635)
Jin, R., Clark, S., Weeks, A. M., Dudman, J. T., Gouaux, E. and Partin, K. M. (2005) Mechanism of positive allosteric modulators acting on AMPA receptors. J. Neurosci. 25, 9027-9036 (Pubitemid 41384472)
Sun, Y., Olson, R., Horning, M., Armstrong, N., Mayer, M. and Gouaux, E. (2002) Mechanism of glutamate receptor desensitization. Nature 417, 245-253 (Pubitemid 34534700)
Hald, H., Ahring, P. K., Timmermann, D. B., Liljefors, T., Gajhede, M. and Kastrup, J. S. (2009) Distinct structural features of cyclothiazide are responsible for effects on peak current amplitude and desensitization kinetics at iGluR2. J. Mol. Biol. 391, 906-917
Ptak, C. P., Ahmed, A. H. and Oswald, R. E. (2009) Probing the allosteric modulator binding site of GluR2 with thiazide derivatives. Biochemistry 48, 8594-8602
Freire, E. (2008) Do enthalpy and entropy distinguish first in class from best in class? Drug Discovery Today 13, 869-874
Ahmed, A. H. and Oswald, R. E. (2010) Piracetam defines a new binding site for allosteric modulators of α-amino-3-hydroxy-5-methyl-4-isoxazole- propionic acid (AMPA) receptors. J. Med. Chem. 53, 2197-2203
Ahmed, A. H., Ptak, C. P. and Oswald, R. E. (2010) Molecular mechanism of flop selectivity and subsite recognition for an AMPA receptor allosteric modulator: structures of GluA2 and GluA3 in complexes with PEPA. Biochemistry 49, 2843-2850
Jamieson, C., Basten, S., Campbell, R. A., Cumming, I. A., Gillen, K. J., Gillespie, J., Kazemier, B., Kiczun, M., Lamont, Y., Lyons, A. J. et al. (2010) A novel series of positive modulators of the AMPA receptor: discovery and structure based hit-to-lead studies. Bioorg. Med. Chem. Lett. 20, 5753-5756
Kaae, B. H., Harpsoe, K., Kastrup, J. S., Sanz, A. C., Pickering, D. S., Metzler, B., Clausen, R. P., Gajhede, M., Sauerberg, P., Liljefors, T. and Madsen, U. (2007) Structural proof of a dimeric positive modulator bridging two identical AMPA receptor-binding sites. Chem. Biol. 14, 1294-1303 (Pubitemid 350102246)
Ward, S. E., Harries, M., Aldegheri, L., Andreotti, D., Ballantine, S., Bax, B. D., Harris, A. J., Harker, A. J., Lund, J., Melarange, R. et al. (2010) Discovery of N-[(2S)-5-(6-fluoro- 3-pyridinyl)-2,3-dihydro-1H-inden-2-yl]-2- propanesulfonamide, a novel clinical AMPA receptor positive modulator. J. Med. Chem. 53, 5801-5812
Mosbacher, J., Schoepfer, R., Monyer, H., Burnashev, N., Seeburg, P. H. and Ruppersberg, J. P. (1994) A molecular determinant for submillisecond desensitization in glutamate receptors. Science 266, 1059-1062 (Pubitemid 24373727)
Sommer, B., Keinanen, K., Verdoorn, T. A., Wisden, W., Burnashev, N., Herb, A., Kohler, M., Takagi, T., Sakmann, B. and Seeburg, P. H. (1990) Flip and flop: a cell-specific functional switch in glutamate-operated channels of the CNS. Science 249, 1580-1585
Francotte, P., Tullio, P., Goffin, E., Dintilhac, G., Graindorge, E., Fraikin, P., Lestage, P., Danober, L., Thomas, J. Y., Caignard, D. H. and Pirotte, B. (2007) Design, synthesis, and pharmacology of novel 7-substituted 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxides as positive allosteric modulators of AMPA receptors. J. Med. Chem. 50, 3153-3157 (Pubitemid 47001258)
Sigurskjold, B. W. (2000) Exact analysis of competition ligand binding by displacement isothermal titration calorimetry. Anal. Biochem. 277, 260-266
Zivkovic, I., Thompson, D. M., Bertolino, M., Uzunov, D., DiBella, M., Costa, E. and Guidotti, A. (1995) 7-Chloro-3-methyl-3-4-dihydro-2H-1,2,4 benzothiadiazine S,S-dioxide (IDRA 21): a benzothiadiazine derivative that enhances cognition by attenuating DL-α-amino-2,3-dihydro-5-methyl-3-oxo-4- isoxazolepropanoic acid (AMPA) receptor desensitization. J. Pharmacol. Exp. Ther. 272, 300-309
Leslie, A.G.W. (1992) Recent changes to the MOSFLM package for processing film and image plate data. Joint CCP4+ESF-EAMCB Newsletter on Protein Crystallography No. 26,
McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C. and Read, R. J. (2007) Phaser crystallographic software. J. Appl. Crystallogr. 40, 658-674 (Pubitemid 47080256)
Langer, G., Cohen, S. X., Lamzin, V. S. and Perrakis, A. (2008) Automated macromolecular model building for X-ray crystallography using ARP/wARP version 7. Nat. Protoc. 3, 1171-1179
Emsley, P. and Cowtan, K. (2004) Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60, 2126-2132 (Pubitemid 41742764)
Adams, P. D., Grosse-Kunstleve, R. W., Hung, L. W., Ioerger, T. R., McCoy, A. J., Moriarty, N. W., Read, R. J., Sacchettini, J. C., Sauter, N. K. and Terwilliger, T. C. (2002) PHENIX: building new software for automated crystallographic structure determination. Acta Crystallogr. D Biol. Crystallogr. 58, 1948-1954 (Pubitemid 35337293)
Schuttelkopf, A. W. and van Aalten, D. M. (2004) PRODRG: a tool for high-throughput crystallography of protein-ligand complexes. Acta Crystallogr. D Biol. Crystallogr. 60, 1355-1363 (Pubitemid 41079731)
Hayward, S. and Berendsen, H. J. (1998) Systematic analysis of domain motions in proteins from conformational change: new results on citrate synthase and T4 lysozyme. Proteins 30, 144-154 (Pubitemid 28080149)
Wiseman, T., Williston, S., Brandts, J. F. and Lin, L. N. (1989) Rapid measurement of binding constants and heats of binding using a new titration calorimeter. Anal. Biochem. 179, 131-137 (Pubitemid 19149635)
Nusser, E., Banerjee, A. and Gal, J. (1991) Excavations in drug chirality: 1. Cyclothiazide. Chirality 3, 2-13
Pirotte, B., Francotte, P., Goffin, E., Fraikin, P., Danober, L., Lesur, B., Botez, I., Caignard, D. H., Lestage, P. and de Tullio, P. (2010) Ring-fused thiadiazines as core structures for the development of potent AMPA receptor potentiators. Curr. Med. Chem. 17, 3575-3582
Yamada, K. A. and Rothman, S. M. (1992) Diazoxide blocks glutamate desensitization and prolongs excitatory postsynaptic currents in rat hippocampal neurons. J. Physiol. 458, 409-423 (Pubitemid 23024600)
Randle, J. C., Biton, C. and Lepagnol, J. M. (1993) Allosteric potentiation by diazoxide of AMPA receptor currents and synaptic potentials. Eur. J. Pharmacol. 247, 257-265
Yamada, K. A. and Tang, C. M. (1993) Benzothiadiazides inhibit rapid glutamate receptor desensitization and enhance glutamatergic synaptic currents. J. Neurosci. 13, 3904-3915 (Pubitemid 23264374)
Hansen, N. T., Kouskoumvekaki, I., Jorgensen, F. S., Brunak, S. and Jonsdottir, S. O. (2006) Prediction of pH-dependent aqueous solubility of druglike molecules. J. Chem. Inf. Model. 46, 2601-2609 (Pubitemid 46008131)
Bertolino, M., Baraldi, M., Parenti, C., Braghiroli, D., DiBella, M., Vicini, S. and Costa, E. (1993) Modulation of AMPA/kainate receptors by analogues of diazoxide and cyclothiazide in thin slices of rat hippocampus. Receptors Channels 1, 267-278 (Pubitemid 2036636)
Thompson, D. M., Guidotti, A., DiBella, M. and Costa, E. (1995) 7-Chloro-3- methyl-3,4-dihydro-2H-1,2,4-benzothiadiazine S,S-dioxide (IDRA 21), a congener of aniracetam, potently abates pharmacologically induced cognitive impairments in patas monkeys. Proc. Natl. Acad. Sci. U.S.A. 92, 7667-7671
Francotte, P., de Tullio, P., Podona, T., Diouf, O., Fraikin, P., Lestage, P., Danober, L., Thomas, J. Y., Caignard, D. H. and Pirotte, B. (2008) Synthesis and pharmacological evaluation of a second generation of pyridothiadiazine 1,1-dioxides acting as AMPA potentiators. Bioorg. Med. Chem. 16, 9948-9956
Pirotte, B., Podona, T., Diouf, O., de Tullio, P., Lebrun, P., Dupont, L., Somers, F., Delarge, J., Morain, P., Lestage, P. et al. (1998) 4H-1,2,4-Pyridothiadiazine 1,1-dioxides and 2,3-dihydro-4H-1,2,4- pyridothiadiazine 1,1-dioxides chemically related to diazoxide and cyclothiazide as powerful positive allosteric modulators of (R /S) -2-amino-3- (3-hydroxy-5-methylisoxazol-4-yl)propionic acid receptors: design, synthesis, pharmacology, and structure-activity relationships. J. Med. Chem. 41, 2946-2959 (Pubitemid 28359930)
